Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank_resource:DB00655_DB00932_nanopub.RAputOrgVF_RMFi9VNfySsJKmw912RNFjDLXFY16Lgq4I#assertion>. }
Showing items 1 to 6 of
6
with 100 items per page.
- drugbank_resource:DB00655_DB00932 type drugbank_vocabulary:Drug-Drug-Interaction assertion.
- drugbank_resource:DB00655_DB00932 label "DDI between Estrone and Tipranavir - Estropipate may increase the adverse dermatological effects (i.e. skin rash) of Tipranavir. Tipranavir may decrease the serum concentration Estropipate. Monitor for estrogen deficiency during concomitant therapy. [drugbank_resource:DB00655_DB00932]" assertion.
- drugbank_resource:DB00655_DB00932 identifier "drugbank_resource:DB00655_DB00932" assertion.
- drugbank_resource:DB00655_DB00932 title "DDI between Estrone and Tipranavir - Estropipate may increase the adverse dermatological effects (i.e. skin rash) of Tipranavir. Tipranavir may decrease the serum concentration Estropipate. Monitor for estrogen deficiency during concomitant therapy." assertion.
- drugbank:DB00932 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00655_DB00932 assertion.
- drugbank:DB00655 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00655_DB00932 assertion.